Gabapentin Capsule
Product Images NDC 71335-0351

11 FDA label images from Bryant Ranch Prepack · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71335-0351). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 1)

1 (Image 1)
A chemical structure diagram depicting the molecular structure of Gabapentin, showing its atoms and bonds represented in a standard chemical formula layout.*
FDA Label Image

1 (Image 2)

1 (Image 2)
Gabapentin 400 mg oral capsules in a blister pack with capsules visible. The image shows one strip of capsules inside a transparent blister, with a white backing. The labeler is Bryant Ranch Prepack.*
FDA Label Image

1 (Image 3)

1 (Image 3)
Gabapentin 400 mg oral capsules in a blister pack. The image shows six yellow capsules arranged in two rows of three within a transparent plastic blister, backed by a foil sheet. No additional text or branding visible on this blister pack image.*
FDA Label Image

1 (Image 4)

1 (Image 4)
Gabapentin 400 mg oral capsules in a high-density polyethylene bottle labeled by Bryant Ranch Prepack, displaying the NDC 71335-0351. The bottle label includes dosing and usage information, manufacturer details, and safety warnings visible on the front and side panels.*
FDA Label Image

1 (Image 5)

1 (Image 5)
Chemical structure diagram of the active ingredient Gabapentin showing its molecular arrangement including hexane ring and amino acid functional groups.*
FDA Label Image

1 (Image 6)

1 (Image 6)
A line graph depicting mean pain score over an 8-week period comparing placebo and gabapentin 3600 mg/day. The x-axis shows weeks including a baseline, divided into a 4-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain scores ranging from 0 to 10. The gabapentin group shows a decreasing trend in pain scores, while the placebo group remains relatively stable.*
FDA Label Image

2 (Image 7)

2 (Image 7)
A line graph showing mean pain scores over a 7-week period comparing placebo with Gabapentin at doses of 1800 mg/day and 2400 mg/day. The x-axis represents weeks, including a 3-week dose titration period and a 4-week fixed dose period, while the y-axis shows mean pain score values from 0 to 10.*
FDA Label Image

3 (Image 8)

3 (Image 8)
A bar chart comparing percentage outcomes in two studies labeled Study 1 and Study 2. Each study compares placebo (PBO) with Gabapentin (GBP) at different doses: 3600 mg in Study 1, and 1800 mg and 2400 mg in Study 2. Percent values are shown above each bar, with statistical significance markers indicating p<0.01 and p<0.001.*
FDA Label Image

4 (Image 9)

4 (Image 9)
A scatter plot comparing differences in percentage by daily dose (mg) for Gabapentin studied in three separate studies labeled a, b, and c. The x-axis indicates daily dose ranging from 600 to 1800 mg, and the y-axis shows difference percentages from 2 to 22%. The graph displays varied differences across doses and studies, with marker shapes and colors distinguishing each study.*
FDA Label Image

Label Image (Lbl713350351)

Label Image (Lbl713350351)
Label for Gabapentin Capsules, USP, 400 mg by Bryant Ranch Prepack. The label includes storage instructions, a warning about dizziness, a barcode, and states the package contains 20 capsules. The product is marked Rx only and has NDC 71335-351-01.*
FDA Label Image

Lbl7133503512

Lbl7133503512
Gabapentin 400 mg capsule label packaged by Bryant Ranch Prepack. The capsule is described as orange/light brown. The label includes storage instructions at 20-25°C (68-77°F), a warning that the medication may cause dizziness, and a directive to keep drugs out of reach of children. The label references comparison to Neurontin 400 mg capsule by Watson Pharma Private Limited and indicates a quantity of 20 capsules. The label also shows the National Drug Code 71335-0351-1 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.